A Harris Interactive/BBK Healthcare Poll showed that more Americans are considering clinical research studies as treatment options and they want more education about the federal and international measures designed to protect them. According to a press release on "The Will & Why Survey," 83 percent of the 5000 respondents to the nationwide online survey said they would consider a clinical research study, but only 13 percent said they have had the opportunity to take part in one. "The survey supports the belief that clinical research studies are perceived by the public as treatment options. This is an important trend because at the rapid rate with which new therapies are coming to market, clinical research studies must be evaluated in every patient's fight plan," BBK Healthcare Inc. CEO Joan F. Bachenheimer said. Additional survey results will be available at the 37th Annual Drug Information Association Meeting taking place July 8-12, 2001.